The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen-Reference-Cited by-同舟云学术

The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen

Author:

Cona Brandon¹,Hayashi Tomoatsu¹,Yamada Ai¹,Shimizu Naomi¹,Yokota Naoko²,Nakato Ryuichiro²,Shirahige Katsuhiko³,Akiyama Tetsu¹^ORCID

Affiliation:

1. Laboratory of Molecular and Genetic Information Institute of Quantitative Biosciences The University of Tokyo Japan

2. Laboratory of Computational Genetics Institute of Quantitative Biosciences The University of Tokyo Japan

3. Laboratory of Genome Structure and Function Institute of Quantitative Biosciences The University of Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

Reference40 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献